TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, 12-week, Double-blind, Randomised, Parallel-group, Active-controlled, Multinational, Efficacy and Safety Study of Symbicort® Turbuhaler® 160/4.5 μg 2 Inhalations Twice Daily (Bid) Compared to Oxis® Turbuhaler® 4.5 μg 2 Inhalations Twice Daily (Bid) in Patients With Chronic Obstructive Pulmonary Disease
Brief Summary: The primary purpose of the study is to investigate if Symbicort is more effective than Oxis in increasing forced expiratory volume in one second (FEV1), measured at the clinics, in patients with COPD.


Options:
A: Arm Label: Tiotropium + Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium bromide, Drug: Placebo Salmeterol | Arm Label: Salmeterol + Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol, Drug: Placebo Tiotropium | Intervention Type: DRUG; Name: Tiotropium bromide; Assigned to Arm(s): Tiotropium + Placebo | Intervention Type: DRUG; Name: Salmeterol; Assigned to Arm(s): Salmeterol + Placebo | Intervention Type: DRUG; Name: Placebo Salmeterol; Assigned to Arm(s): Tiotropium + Placebo | Intervention Type: DRUG; Name: Placebo Tiotropium; Assigned to Arm(s): Salmeterol + Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Budesonide/formoterol (Symbicort Turbuhaler) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol (Oxis Turbuhaler) | Intervention Type: DRUG; Name: Budesonide/formoterol (Symbicort Turbuhaler); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Formoterol (Oxis Turbuhaler); Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: Salmeterol 50mcg/ Fluticasone Propionate 500mcg; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Formoterol; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, 12-week, Double-blind, Randomised, Parallel-group, Active-controlled, Multinational, Efficacy and Safety Study of Symbicort® Turbuhaler® 160/4.5 μg 2 Inhalations Twice Daily (Bid) Compared to Oxis® Turbuhaler® 4.5 μg 2 Inhalations Twice Daily (Bid) in Patients With Chronic Obstructive Pulmonary Disease
Brief Summary: The primary purpose of the study is to investigate if Symbicort is more effective than Oxis in increasing forced expiratory volume in one second (FEV1), measured at the clinics, in patients with COPD.


Options:
A: Intervention Type: DRUG; Name: Budesonide/formoterol pMDI; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Budesonide pMDI; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Formoterol Turbuhaler; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Budesonide/formoterol (Symbicort Turbuhaler) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol (Oxis Turbuhaler) | Intervention Type: DRUG; Name: Budesonide/formoterol (Symbicort Turbuhaler); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Formoterol (Oxis Turbuhaler); Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: Fluticasone 500mcg BD via accuhaler or identical placebo; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Salmeterol 50mcg/ Fluticasone Propionate 500mcg; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Brief Summary: The purpose of this trial is to investigate whether irrigation solution (soap vs. saline solution), or irrigation pressure (high vs. low) will decrease the rate of infection among patients with open fracture wounds.


Options:
A: Intervention Type: PROCEDURE; Name: Intra-peritoneal antibiotic lavage; Assigned to Arm(s): N/A
B: Arm Label: Gentamicin lavage; Type: EXPERIMENTAL; Interventions: Drug: Axillary lavage with gentamicin solution | Arm Label: Normal saline lavage; Type: ACTIVE_COMPARATOR; Interventions: Drug: Axillary lavage with gentamicin solution | Intervention Type: DRUG; Name: Axillary lavage with gentamicin solution; Assigned to Arm(s): Gentamicin lavage, Normal saline lavage
C: Arm Label: local instillation of morphine 5 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: local instillation of morphine to surgical wound | Arm Label: local instillation of morphine 10 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: local instillation of morphine to surgical wound | Arm Label: local instillation of morphine 15 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: local instillation of morphine to surgical wound | Arm Label: local instillation of local anesthetics; Type: PLACEBO_COMPARATOR; Interventions: Drug: local instillation of morphine to surgical wound | Intervention Type: DRUG; Name: local instillation of morphine to surgical wound; Assigned to Arm(s): local instillation of local anesthetics, local instillation of morphine 10 mg, local instillation of morphine 15 mg, local instillation of morphine 5 mg
D: Arm Label: Normal saline and High pressure; Type: EXPERIMENTAL; Interventions: Procedure: Type of fluid lavage solution, Procedure: Type of fluid lavage pressure | Arm Label: Soap solution and High pressure; Type: EXPERIMENTAL; Interventions: Procedure: Type of fluid lavage solution, Procedure: Type of fluid lavage pressure | Arm Label: Normal saline and Low pressure; Type: EXPERIMENTAL; Interventions: Procedure: Type of fluid lavage solution, Procedure: Type of fluid lavage pressure | Arm Label: Soap solution and Low pressure; Type: EXPERIMENTAL; Interventions: Procedure: Type of fluid lavage solution, Procedure: Type of fluid lavage pressure | Intervention Type: PROCEDURE; Name: Type of fluid lavage solution; Assigned to Arm(s): Normal saline and High pressure, Normal saline and Low pressure, Soap solution and High pressure, Soap solution and Low pressure | Intervention Type: PROCEDURE; Name: Type of fluid lavage pressure; Assigned to Arm(s): Normal saline and High pressure, Normal saline and Low pressure, Soap solution and High pressure, Soap solution and Low pressure

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Postpartum Pelvic Floor Muscle Training in Women With Injured and Non-injured Pelvic Floor Muscles. A Single Blind Randomized Controlled Trial
Brief Summary: Although pregnancy and childbirth are associated with happiness and a positive life change for most women, it can also be considered as risk periods for injuries to the pelvic floor and development of pelvic floor dysfunction. This may leed to devastating loss of function and quality of life (Ashton-Miller \& DeLancey 2007).

The aim of this study is to evaluate the effect of postpartum pelvic floor muscle training for primiparous women with and without pelvic floor muscle injury.


Options:
A: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise classes with pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise classes with pelvic floor muscle training; Assigned to Arm(s): Exercise group
B: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise
C: Arm Label: Postpartum pelvic floor muscle training; Type: EXPERIMENTAL; Interventions: Other: Postpartum pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Postpartum pelvic floor muscle training; Assigned to Arm(s): Postpartum pelvic floor muscle training
D: Arm Label: Exercise training; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Postpartum Pelvic Floor Muscle Training in Women With Injured and Non-injured Pelvic Floor Muscles. A Single Blind Randomized Controlled Trial
Brief Summary: Although pregnancy and childbirth are associated with happiness and a positive life change for most women, it can also be considered as risk periods for injuries to the pelvic floor and development of pelvic floor dysfunction. This may leed to devastating loss of function and quality of life (Ashton-Miller \& DeLancey 2007).

The aim of this study is to evaluate the effect of postpartum pelvic floor muscle training for primiparous women with and without pelvic floor muscle injury.


Options:
A: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise Group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Group | Intervention Type: BEHAVIORAL; Name: Exercise Group; Assigned to Arm(s): Exercise Group
B: Arm Label: Group Behavioral Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Group Behavioral Treatment | Arm Label: No Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Group Behavioral Treatment; Assigned to Arm(s): Group Behavioral Treatment
C: Arm Label: PFMT&HE group; Type: EXPERIMENTAL; Interventions: Other: PFM training, Other: HE, Behavioral: Educational strategy | Arm Label: HE group; Type: EXPERIMENTAL; Interventions: Other: HE, Behavioral: Educational strategy | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational strategy | Intervention Type: OTHER; Name: PFM training; Assigned to Arm(s): PFMT&HE group | Intervention Type: OTHER; Name: HE; Assigned to Arm(s): HE group, PFMT&HE group | Intervention Type: BEHAVIORAL; Name: Educational strategy; Assigned to Arm(s): Control group, HE group, PFMT&HE group
D: Arm Label: Postpartum pelvic floor muscle training; Type: EXPERIMENTAL; Interventions: Other: Postpartum pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Postpartum pelvic floor muscle training; Assigned to Arm(s): Postpartum pelvic floor muscle training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Postpartum Pelvic Floor Muscle Training in Women With Injured and Non-injured Pelvic Floor Muscles. A Single Blind Randomized Controlled Trial
Brief Summary: Although pregnancy and childbirth are associated with happiness and a positive life change for most women, it can also be considered as risk periods for injuries to the pelvic floor and development of pelvic floor dysfunction. This may leed to devastating loss of function and quality of life (Ashton-Miller \& DeLancey 2007).

The aim of this study is to evaluate the effect of postpartum pelvic floor muscle training for primiparous women with and without pelvic floor muscle injury.


Options:
A: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group
B: Arm Label: G1; Type: EXPERIMENTAL; Interventions: Procedure: Pregnants for receive the physical therapy guide | Intervention Type: PROCEDURE; Name: Pregnants for receive the physical therapy guide; Assigned to Arm(s): G1
C: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise classes with pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise classes with pelvic floor muscle training; Assigned to Arm(s): Exercise group
D: Arm Label: Postpartum pelvic floor muscle training; Type: EXPERIMENTAL; Interventions: Other: Postpartum pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Postpartum pelvic floor muscle training; Assigned to Arm(s): Postpartum pelvic floor muscle training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of a Multifaceted Intervention on the Preventability of Infections in Residents of French Nursing Homes: Cluster-randomised Controlled Trial (ENLIL Study)
Brief Summary: STUDY HYPOTHESIS : An infection prevention program adapted for the nursing home context can reduce by 5% the number of infections (urinary, upper and lower respiratory and gastrointestinal) in elderly residents in nursing homes.

STUDY DESIGN : The proposal is for an interventional cluster (nursing home) study comprising 2 randomized groups: group 1 (interventional), comprising 25 nursing homes implementing a specific infection prevention program; and group 2 (control), 25 nursing homes continuing to implement their routine prevention measures.


Options:
A: Arm Label: Intervention Nursing Homes; Type: EXPERIMENTAL; Interventions: Other: Prevention of infections program | Arm Label: Usual care Nursing Homes; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Prevention of infections program; Assigned to Arm(s): Intervention Nursing Homes
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Soap | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Soap; Assigned to Arm(s): 1
C: Arm Label: Green tea; Type: EXPERIMENTAL; Interventions: Dietary Supplement: green tea | Arm Label: water; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: green tea | Intervention Type: DIETARY_SUPPLEMENT; Name: green tea; Assigned to Arm(s): Green tea, water
D: Arm Label: 1. Surgical; Type: ACTIVE_COMPARATOR; Interventions: Device: Surgical mask | Arm Label: 2. N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 mask | Intervention Type: DEVICE; Name: Surgical mask; Assigned to Arm(s): 1. Surgical | Intervention Type: DEVICE; Name: N95 mask; Assigned to Arm(s): 2. N95 Respirator

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of a Multifaceted Intervention on the Preventability of Infections in Residents of French Nursing Homes: Cluster-randomised Controlled Trial (ENLIL Study)
Brief Summary: STUDY HYPOTHESIS : An infection prevention program adapted for the nursing home context can reduce by 5% the number of infections (urinary, upper and lower respiratory and gastrointestinal) in elderly residents in nursing homes.

STUDY DESIGN : The proposal is for an interventional cluster (nursing home) study comprising 2 randomized groups: group 1 (interventional), comprising 25 nursing homes implementing a specific infection prevention program; and group 2 (control), 25 nursing homes continuing to implement their routine prevention measures.


Options:
A: Arm Label: Group 1 Standard; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Group 2 Enhanced Standard; Type: ACTIVE_COMPARATOR; Interventions: Other: Supplemental training, education and hygiene | Arm Label: Group 3 Chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine gluconate, Other: Supplemental training, education and hygiene | Intervention Type: DRUG; Name: Chlorhexidine gluconate; Assigned to Arm(s): Group 3 Chlorhexidine | Intervention Type: OTHER; Name: Supplemental training, education and hygiene; Assigned to Arm(s): Group 2 Enhanced Standard, Group 3 Chlorhexidine
B: Arm Label: N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 Respirator | Arm Label: Medical/surgical mask; Type: ACTIVE_COMPARATOR; Interventions: Device: Medical/surgical mask | Intervention Type: DEVICE; Name: N95 Respirator; Assigned to Arm(s): N95 Respirator | Intervention Type: DEVICE; Name: Medical/surgical mask; Assigned to Arm(s): Medical/surgical mask
C: Arm Label: Intervention Nursing Homes; Type: EXPERIMENTAL; Interventions: Other: Prevention of infections program | Arm Label: Usual care Nursing Homes; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Prevention of infections program; Assigned to Arm(s): Intervention Nursing Homes
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Alcohol-based hand sanitizer & quaternary ammonium wipes | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alcohol-based hand sanitizer & quaternary ammonium wipes; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Randomized, Placebo-controlled Multi-center Trial to Compare the Phosphate Lowering Efficacy of Different Doses of SBR759 to Placebo
Brief Summary: This study will compare placebo to 4 different doses of SBR759 to assess the phosphate lowering efficacy in dialysis patients.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sevelamer carbonate | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sevelamer carbonate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Arm 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: SBR759A | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Arm Label: arm 4; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Arm Label: arm 5; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): arm 4 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): arm 5
C: Arm Label: PhosLo; Type: EXPERIMENTAL; Interventions: Drug: calcium acetate | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: calcium acetate; Assigned to Arm(s): PhosLo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: HS219; Type: EXPERIMENTAL; Interventions: Dietary Supplement: HS219 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: HS219; Assigned to Arm(s): HS219 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Brief Summary: To determine the safety and effectiveness of PEVAR.


Options:
A: Arm Label: FemoSeal®; Type: EXPERIMENTAL; Interventions: Device: FemoSeal® | Arm Label: Manual compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual compression | Intervention Type: DEVICE; Name: FemoSeal®; Assigned to Arm(s): FemoSeal® | Intervention Type: OTHER; Name: Manual compression; Assigned to Arm(s): Manual compression
B: Arm Label: Manual Compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual Compression | Arm Label: Vascular Closure Device; Type: EXPERIMENTAL; Interventions: Device: Vascular Closure Device | Intervention Type: OTHER; Name: Manual Compression; Assigned to Arm(s): Manual Compression | Intervention Type: DEVICE; Name: Vascular Closure Device; Assigned to Arm(s): Vascular Closure Device
C: Arm Label: FemoSeal®; Type: EXPERIMENTAL; Interventions: Device: FemoSeal® | Arm Label: ExoSeal®; Type: EXPERIMENTAL; Interventions: Device: ExoSeal® | Arm Label: Manual compression; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual compression | Intervention Type: DEVICE; Name: FemoSeal®; Assigned to Arm(s): FemoSeal® | Intervention Type: DEVICE; Name: ExoSeal®; Assigned to Arm(s): ExoSeal® | Intervention Type: OTHER; Name: Manual compression; Assigned to Arm(s): Manual compression
D: Arm Label: Standard EVAR (IntuiTrak); Type: ACTIVE_COMPARATOR; Interventions: Device: SEVAR (IntuiTrak) | Arm Label: PEVAR (ProGlide closure); Type: EXPERIMENTAL; Interventions: Device: PEVAR (ProGlide closure) | Arm Label: PEVAR (ProstarXL closure); Type: EXPERIMENTAL; Interventions: Device: PEVAR (Prostar XL closure) | Intervention Type: DEVICE; Name: PEVAR (ProGlide closure); Assigned to Arm(s): PEVAR (ProGlide closure) | Intervention Type: DEVICE; Name: SEVAR (IntuiTrak); Assigned to Arm(s): Standard EVAR (IntuiTrak) | Intervention Type: DEVICE; Name: PEVAR (Prostar XL closure); Assigned to Arm(s): PEVAR (ProstarXL closure)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Duloxetine Versus Placebo in the Acute Treatment of Patients With Major Depressive Disorder and Associated Painful Physical Symptoms
Brief Summary: The purpose of this study is to find out if 60 mg of duloxetine given once a day by mouth for 8 weeks to patients diagnosed with major depressive disorder, who also report associated painful physical symptoms, is better than placebo when treating depression and its associated painful symptoms.


Options:
A: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Placebo | Arm Label: Pregabalin+Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Pregabalin, Drug: Placebo | Arm Label: Pregabalin; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin, Drug: Placebo | Arm Label: Duloxetine + Pregabalin; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Pregabalin, Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine, Duloxetine + Pregabalin, Pregabalin+Duloxetine | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Duloxetine + Pregabalin, Pregabalin, Pregabalin+Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Duloxetine, Duloxetine + Pregabalin, Pregabalin, Pregabalin+Duloxetine
B: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: duloxetine hydrochloride; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A

Answer: B